{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T00:40:37Z","timestamp":1794184837133,"version":"4.8.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"8067","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2025,6,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Somatic\n                    <jats:italic>DNMT3A<\/jats:italic>\n                    -R882 codon mutations drive the most common form of clonal haematopoiesis (CH) and are associated with increased acute myeloid leukaemia (AML) risk\n                    <jats:sup>1,2<\/jats:sup>\n                    . Preventing expansion of\n                    <jats:italic>DNMT3A<\/jats:italic>\n                    -R882-mutant haematopoietic stem\/progenitor cells (HSPCs) may therefore avert progression to AML. To identify\n                    <jats:italic>DNMT3A<\/jats:italic>\n                    -R882-mutant-specific vulnerabilities, we conducted a genome-wide CRISPR screen on primary mouse\n                    <jats:italic>Dnmt3a<\/jats:italic>\n                    <jats:sup>R882H\/+<\/jats:sup>\n                    HSPCs. Among the 640 vulnerability genes identified, many were involved in mitochondrial metabolism, and metabolic flux analysis confirmed enhanced oxidative phosphorylation use in\n                    <jats:italic>Dnmt3a<\/jats:italic>\n                    <jats:sup>R882H\/+<\/jats:sup>\n                    versus\n                    <jats:italic>Dnmt3a<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>+\/+<\/jats:italic>\n                    <\/jats:sup>\n                    (WT) HSPCs. We selected citrate\/malate transporter\n                    <jats:italic>Slc25a1<\/jats:italic>\n                    and complex I component\n                    <jats:italic>Ndufb11<\/jats:italic>\n                    , for which pharmacological inhibitors are available, for downstream studies. In vivo administration of SLC25A1 inhibitor CTPI2 and complex I inhibitors IACS-010759 and metformin suppressed post-transplantation clonal expansion of\n                    <jats:italic>Dnmt3a<\/jats:italic>\n                    <jats:sup>R882H\/+<\/jats:sup>\n                    , but not WT, long-term haematopoietic stem cells. The effect of metformin was recapitulated using a primary human\n                    <jats:italic>DNMT3A<\/jats:italic>\n                    -R882 CH sample. Notably, analysis of 412,234 UK Biobank participants showed that individuals taking metformin had a markedly lower prevalence of\n                    <jats:italic>DNMT3A<\/jats:italic>\n                    -R882-mutant CH, after controlling for potential confounders including glycated haemoglobin, diabetes and body mass index. Collectively, our data propose modulation of mitochondrial metabolism as a therapeutic strategy for prevention of\n                    <jats:italic>DNMT3A<\/jats:italic>\n                    -R882-mutant AML.\n                  <\/jats:p>","DOI":"10.1038\/s41586-025-08980-6","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T11:03:04Z","timestamp":1744801384000},"page":"431-441","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesis"],"prefix":"10.1038","volume":"642","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3134-1276","authenticated-orcid":false,"given":"Malgorzata","family":"Gozdecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muxin","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0054-7503","authenticated-orcid":false,"given":"Richard J.","family":"Stopforth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Rak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristi","family":"Damaskou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guinevere L.","family":"Grice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4782-5718","authenticated-orcid":false,"given":"Matthew A.","family":"McLoughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6115-655X","authenticated-orcid":false,"given":"Laura","family":"Bond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5129-7295","authenticated-orcid":false,"given":"Rachael","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1390-6592","authenticated-orcid":false,"given":"George","family":"Giotopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya Mahalingam","family":"Shanmugiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5643-0195","authenticated-orcid":false,"given":"Rula Bany","family":"Bakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2913-0012","authenticated-orcid":false,"given":"Eliza","family":"Yankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4106-2166","authenticated-orcid":false,"given":"Nisha","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8418-5783","authenticated-orcid":false,"given":"Sarah J.","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Asby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean C.","family":"Pask","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Mupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Duddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Marando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros","family":"Georgomanolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirtha Priya","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7452-2536","authenticated-orcid":false,"given":"Clea","family":"Barcena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7254-2253","authenticated-orcid":false,"given":"Paolo","family":"Gallipoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Yusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slav\u00e9","family":"Petrovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7793-6291","authenticated-orcid":false,"given":"Pedro M.","family":"Quiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3293-7397","authenticated-orcid":false,"given":"Christian","family":"Frezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0248-1632","authenticated-orcid":false,"given":"James A.","family":"Nathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1419-3344","authenticated-orcid":false,"given":"Arthur","family":"Kaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhartha","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4865-7648","authenticated-orcid":false,"given":"Konstantinos","family":"Tzelepis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3792-4058","authenticated-orcid":false,"given":"Jonathan","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7794-610X","authenticated-orcid":false,"given":"Margarete A.","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0312-161X","authenticated-orcid":false,"given":"Brian J. P.","family":"Huntly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4337-8022","authenticated-orcid":false,"given":"George S.","family":"Vassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"key":"8980_CR1","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41588-023-01472-1","volume":"55","author":"M Gu","year":"2023","unstructured":"Gu, M. et al. Multiparameter prediction of myeloid neoplasia risk. Nat. Genet. 55, 1523\u20131530 (2023).","journal-title":"Nat. Genet."},{"key":"8980_CR2","doi-asserted-by":"publisher","unstructured":"Weeks, L. D. et al. Prediction of risk for myeloid malignancy in clonal hematopoiesis. NEJM Evid. https:\/\/doi.org\/10.1056\/evidoa2200310 (2023).","DOI":"10.1056\/evidoa2200310"},{"key":"8980_CR3","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","volume":"371","author":"S Jaiswal","year":"2014","unstructured":"Jaiswal, S. et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371, 2488\u20132498 (2014).","journal-title":"N. Engl. J. Med."},{"key":"8980_CR4","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","volume":"371","author":"G Genovese","year":"2014","unstructured":"Genovese, G. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371, 2477\u20132487 (2014).","journal-title":"N. Engl. J. Med."},{"key":"8980_CR5","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1038\/nm.3733","volume":"20","author":"M Xie","year":"2014","unstructured":"Xie, M. et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat. Med. 20, 1472\u20131478 (2014).","journal-title":"Nat. Med."},{"key":"8980_CR6","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.celrep.2015.02.005","volume":"10","author":"T McKerrell","year":"2015","unstructured":"McKerrell, T. et al. Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis. Cell Rep 10, 1239\u20131245 (2015).","journal-title":"Cell Rep"},{"key":"8980_CR7","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature13038","volume":"506","author":"LI Shlush","year":"2014","unstructured":"Shlush, L. I. et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature 506, 328\u2013333 (2014).","journal-title":"Nature"},{"key":"8980_CR8","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1056\/NEJMoa1005143","volume":"363","author":"TJ Ley","year":"2010","unstructured":"Ley, T. J. et al. DNMT3A mutations in acute myeloid leukemia. N. Engl. J. Med. 363, 2424\u20132433 (2010).","journal-title":"N. Engl. J. Med."},{"key":"8980_CR9","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ccr.2014.02.010","volume":"25","author":"DA Russler-Germain","year":"2014","unstructured":"Russler-Germain, D. A. et al. The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers. Cancer Cell 25, 442\u2013454 (2014).","journal-title":"Cancer Cell"},{"key":"8980_CR10","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1182\/blood-2013-02-483487","volume":"122","author":"SJ Kim","year":"2013","unstructured":"Kim, S. J. et al. A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells. Blood 122, 4086\u20134089 (2013).","journal-title":"Blood"},{"key":"8980_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/ng.1009","volume":"44","author":"GA Challen","year":"2011","unstructured":"Challen, G. A. et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat. Genet. 44, 23\u201331 (2011).","journal-title":"Nat. Genet."},{"key":"8980_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2018.03.025","volume":"23","author":"M Jeong","year":"2018","unstructured":"Jeong, M. et al. Loss of Dnmt3a immortalizes hematopoietic stem cells in vivo. Cell Rep. 23, 1\u201310 (2018).","journal-title":"Cell Rep."},{"key":"8980_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10924","volume":"7","author":"J Koya","year":"2016","unstructured":"Koya, J. et al. DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation. Nat. Commun. 7, 10924 (2016).","journal-title":"Nat. Commun."},{"key":"8980_CR14","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1158\/2159-8290.CD-22-0086","volume":"12","author":"JM SanMiguel","year":"2022","unstructured":"SanMiguel, J. M. et al. Distinct tumor necrosis factor alpha receptors dictate stem cell fitness versus lineage output in Dnmt3a-mutant clonal hematopoiesis. Cancer Discov. 12, 2763\u20132773 (2022).","journal-title":"Cancer Discov."},{"key":"8980_CR15","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.stem.2021.03.002","volume":"28","author":"D Hormaechea-Agulla","year":"2021","unstructured":"Hormaechea-Agulla, D. et al. Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFN\u03b3 signaling. Cell Stem Cell 28, 1428\u20131442.e1426 (2021).","journal-title":"Cell Stem Cell"},{"key":"8980_CR16","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/nm.4210","volume":"22","author":"OA Guryanova","year":"2016","unstructured":"Guryanova, O. A. et al. DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling. Nat. Med. 22, 1488\u20131495 (2016).","journal-title":"Nat. Med."},{"key":"8980_CR17","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1038\/s41375-018-0368-6","volume":"33","author":"MA Loberg","year":"2019","unstructured":"Loberg, M. A. et al. Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis. Leukemia 33, 1635\u20131649 (2019).","journal-title":"Leukemia"},{"key":"8980_CR18","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.3324\/haematol.2018.215269","volume":"104","author":"AL Young","year":"2019","unstructured":"Young, A. L., Tong, R. S., Birmann, B. M. & Druley, T. E. Clonal hematopoiesis and risk of acute myeloid leukemia. Haematologica 104, 2410\u20132417 (2019).","journal-title":"Haematologica"},{"key":"8980_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.849376","volume":"12","author":"M Jawad","year":"2022","unstructured":"Jawad, M. et al. DNMT3A R882 mutations confer unique clinicopathologic features in MDS including a high risk of AML transformation. Front. Oncol. 12, 849376 (2022).","journal-title":"Front. Oncol."},{"key":"8980_CR20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s43018-021-00213-9","volume":"2","author":"M Scheller","year":"2021","unstructured":"Scheller, M. et al. Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response. Nat. Cancer 2, 527\u2013544 (2021).","journal-title":"Nat. Cancer"},{"key":"8980_CR21","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41420-021-00697-5","volume":"7","author":"M Liao","year":"2021","unstructured":"Liao, M. et al. Oridonin inhibits DNMT3A R882 mutation-driven clonal hematopoiesis and leukemia by inducing apoptosis and necroptosis. Cell Death Discov. 7, 297 (2021).","journal-title":"Cell Death Discov."},{"key":"8980_CR22","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1182\/blood-2015-11-684225","volume":"128","author":"RE Rau","year":"2016","unstructured":"Rau, R. E. et al. DOT1L as a therapeutic target for the treatment of DNMT3A-mutant acute myeloid leukemia. Blood 128, 971\u2013981 (2016).","journal-title":"Blood"},{"key":"8980_CR23","doi-asserted-by":"publisher","first-page":"5237","DOI":"10.1073\/pnas.1703476114","volume":"114","author":"YJ Dai","year":"2017","unstructured":"Dai, Y. J. et al. Conditional knockin of Dnmt3a R878H initiates acute myeloid leukemia with mTOR pathway involvement. Proc. Natl Acad. Sci. USA 114, 5237\u20135242 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8980_CR24","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.celrep.2016.09.079","volume":"17","author":"K Tzelepis","year":"2016","unstructured":"Tzelepis, K. et al. A CRISPR dropout screen identifies genetic vulnerabilities and therapeutic targets in acute myeloid leukemia. Cell Rep. 17, 1193\u20131205 (2016).","journal-title":"Cell Rep."},{"key":"8980_CR25","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1182\/bloodadvances.2020003443","volume":"5","author":"S Pacharne","year":"2021","unstructured":"Pacharne, S. et al. SETBP1 overexpression acts in the place of class-defining mutations to drive FLT3-ITD-mutant AML. Blood Adv. 5, 2412\u20132425 (2021).","journal-title":"Blood Adv."},{"key":"8980_CR26","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1182\/blood.V99.11.3939","volume":"99","author":"OP Pinto do","year":"2002","unstructured":"Pinto do, O. P., Richter, K. & Carlsson, L. Hematopoietic progenitor\/stem cells immortalized by Lhx2 generate functional hematopoietic cells in vivo. Blood 99, 3939\u20133946 (2002).","journal-title":"Blood"},{"key":"8980_CR27","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41418-018-0101-z","volume":"25","author":"HR Fernandez","year":"2018","unstructured":"Fernandez, H. R. et al. The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer. Cell Death Differ. 25, 1239\u20131258 (2018).","journal-title":"Cell Death Differ."},{"key":"8980_CR28","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1038\/s41418-020-0491-6","volume":"27","author":"M Tan","year":"2020","unstructured":"Tan, M. et al. Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD\/NASH. Cell Death Differ. 27, 2143\u20132157 (2020).","journal-title":"Cell Death Differ."},{"key":"8980_CR29","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","volume":"24","author":"JR Molina","year":"2018","unstructured":"Molina, J. R. et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat. Med. 24, 1036\u20131046 (2018).","journal-title":"Nat. Med."},{"key":"8980_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41591-022-02103-8","volume":"29","author":"TA Yap","year":"2023","unstructured":"Yap, T. A. et al. Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials. Nat. Med. 29, 115\u2013126 (2023).","journal-title":"Nat. Med."},{"key":"8980_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim, J., Kundu, M., Viollet, B. & Guan, K. L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132\u2013141 (2011).","journal-title":"Nat. Cell Biol."},{"key":"8980_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0256-4","volume":"9","author":"JA Machado-Neto","year":"2018","unstructured":"Machado-Neto, J. A. et al. Metformin exerts multitarget antileukemia activity in JAK2(V617F)-positive myeloproliferative neoplasms. Cell Death Dis. 9, 311 (2018).","journal-title":"Cell Death Dis."},{"key":"8980_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep28597","volume":"6","author":"H Xiao","year":"2016","unstructured":"Xiao, H. et al. Metformin is a novel suppressor for transforming growth factor (TGF)-beta1. Sci. Rep. 6, 28597 (2016).","journal-title":"Sci. Rep."},{"key":"8980_CR34","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3390\/cells8010049","volume":"8","author":"S Saladini","year":"2019","unstructured":"Saladini, S. et al. Metformin impairs glutamine metabolism and autophagy in tumour cells. Cells 8, 49 (2019).","journal-title":"Cells"},{"key":"8980_CR35","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ymben.2016.11.004","volume":"43","author":"L Jiang","year":"2017","unstructured":"Jiang, L. et al. Quantitative metabolic flux analysis reveals an unconventional pathway of fatty acid synthesis in cancer cells deficient for the mitochondrial citrate transport protein. Metab. Eng. 43, 198\u2013207 (2017).","journal-title":"Metab. Eng."},{"key":"8980_CR36","doi-asserted-by":"publisher","unstructured":"Kasprzyk-Pawelec, A. et al. Inactivation of the SLC25A1 gene during embryogenesis induces a unique senescence program controlled by p53. Cell Death Differ. https:\/\/doi.org\/10.1038\/s41418-024-01428-w (2024).","DOI":"10.1038\/s41418-024-01428-w"},{"key":"8980_CR37","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s10545-014-9702-y","volume":"37","author":"C M\u00fchlhausen","year":"2014","unstructured":"M\u00fchlhausen, C. et al. Combined D2-\/L2-hydroxyglutaric aciduria (SLC25A1 deficiency): clinical course and effects of citrate treatment. J. Inherit. Metab. Dis. 37, 775\u2013781 (2014).","journal-title":"J. Inherit. Metab. Dis."},{"key":"8980_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","volume":"19","author":"W Xu","year":"2011","unstructured":"Xu, W. et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases. Cancer Cell 19, 17\u201330 (2011).","journal-title":"Cancer Cell"},{"key":"8980_CR39","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1001\/jama.2019.3805","volume":"321","author":"J Flory","year":"2019","unstructured":"Flory, J. & Lipska, K. Metformin in 2019. JAMA 321, 1926\u20131927 (2019).","journal-title":"JAMA"},{"key":"8980_CR40","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1158\/2159-8290.CD-21-0560","volume":"12","author":"YH Huang","year":"2022","unstructured":"Huang, Y. H. et al. Systematic profiling of DNMT3A variants reveals protein instability mediated by the DCAF8 E3 ubiquitin ligase adaptor. Cancer Discov. 12, 220\u2013235 (2022).","journal-title":"Cancer Discov."},{"key":"8980_CR41","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s00125-022-05824-0","volume":"66","author":"KG Young","year":"2023","unstructured":"Young, K. G. et al. The impact of population-level HbA(1c) screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis. Diabetologia 66, 300\u2013309 (2023).","journal-title":"Diabetologia"},{"key":"8980_CR42","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1016\/S2666-7568(23)00085-5","volume":"4","author":"S Luo","year":"2023","unstructured":"Luo, S. et al. Effects of putative metformin targets on phenotypic age and leukocyte telomere length: a mendelian randomisation study using data from the UK Biobank. Lancet Healthy Longev. 4, e337\u2013e344 (2023).","journal-title":"Lancet Healthy Longev."},{"key":"8980_CR43","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41588-021-00852-9","volume":"53","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. The trans-ancestral genomic architecture of glycemic traits. Nat. Genet. 53, 840\u2013860 (2021).","journal-title":"Nat. Genet."},{"key":"8980_CR44","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1038\/s41588-018-0241-6","volume":"50","author":"A Mahajan","year":"2018","unstructured":"Mahajan, A. et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat. Genet. 50, 1505\u20131513 (2018).","journal-title":"Nat. Genet."},{"key":"8980_CR45","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/hmg\/ddy327","volume":"28","author":"SL Pulit","year":"2019","unstructured":"Pulit, S. L. et al. Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry. Hum. Mol. Genet. 28, 166\u2013174 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"8980_CR46","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41586-022-04785-z","volume":"606","author":"MA Fabre","year":"2022","unstructured":"Fabre, M. A. et al. The longitudinal dynamics and natural history of clonal haematopoiesis. Nature 606, 335\u2013342 (2022).","journal-title":"Nature"},{"key":"8980_CR47","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41586-018-0317-6","volume":"559","author":"S Abelson","year":"2018","unstructured":"Abelson, S. et al. Prediction of acute myeloid leukaemia risk in healthy individuals. Nature 559, 400\u2013404 (2018).","journal-title":"Nature"},{"key":"8980_CR48","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41591-018-0114-7","volume":"24","author":"RS Sellar","year":"2018","unstructured":"Sellar, R. S., Jaiswal, S. & Ebert, B. L. Predicting progression to AML. Nat. Med. 24, 904\u2013906 (2018).","journal-title":"Nat. Med."},{"key":"8980_CR49","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41416-020-0920-9","volume":"123","author":"M Kyrgiou","year":"2020","unstructured":"Kyrgiou, M. et al. Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC). Br. J. Cancer 123, 510\u2013517 (2020).","journal-title":"Br. J. Cancer"},{"key":"8980_CR50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/gutjnl-2016-312712","volume":"67","author":"CA Doubeni","year":"2018","unstructured":"Doubeni, C. A. et al. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut 67, 291\u2013298 (2018).","journal-title":"Gut"},{"key":"8980_CR51","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/ncb3529","volume":"19","author":"E Ans\u00f3","year":"2017","unstructured":"Ans\u00f3, E. et al. The mitochondrial respiratory chain is essential for haematopoietic stem cell function. Nat. Cell Biol. 19, 614\u2013625 (2017).","journal-title":"Nat. Cell Biol."},{"key":"8980_CR52","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/nature21388","volume":"543","author":"TT Ho","year":"2017","unstructured":"Ho, T. T. et al. Autophagy maintains the metabolism and function of young and old stem cells. Nature 543, 205\u2013210 (2017).","journal-title":"Nature"},{"key":"8980_CR53","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.stem.2010.07.011","volume":"7","author":"T Simsek","year":"2010","unstructured":"Simsek, T. et al. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell 7, 380\u2013390 (2010).","journal-title":"Cell Stem Cell"},{"key":"8980_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13125","volume":"7","author":"N Vannini","year":"2016","unstructured":"Vannini, N. et al. Specification of haematopoietic stem cell fate via modulation of mitochondrial activity. Nat. Commun. 7, 13125 (2016).","journal-title":"Nat. Commun."},{"key":"8980_CR55","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2012.12.013","volume":"12","author":"ED Lagadinou","year":"2013","unstructured":"Lagadinou, E. D. et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell 12, 329\u2013341 (2013).","journal-title":"Cell Stem Cell"},{"key":"8980_CR56","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.ccell.2018.10.005","volume":"34","author":"CL Jones","year":"2018","unstructured":"Jones, C. L. et al. Inhibition of amino acid metabolism selectively targets human leukemia stem cells. Cancer Cell 34, 724\u2013740 e724 (2018).","journal-title":"Cancer Cell"},{"key":"8980_CR57","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature24294","volume":"551","author":"S Raffel","year":"2017","unstructured":"Raffel, S. et al. BCAT1 restricts alphaKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation. Nature 551, 384\u2013388 (2017).","journal-title":"Nature"},{"key":"8980_CR58","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163968","volume":"133","author":"SK Pasupuleti","year":"2023","unstructured":"Pasupuleti, S. K. et al. Obesity-induced inflammation exacerbates clonal hematopoiesis. J. Clin. Invest. 133, e163968 (2023).","journal-title":"J. Clin. Invest."},{"key":"8980_CR59","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"8980_CR60","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.ccr.2011.10.015","volume":"20","author":"M Skrtic","year":"2011","unstructured":"Skrtic, M. et al. Inhibition of mitochondrial translation as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell 20, 674\u2013688 (2011).","journal-title":"Cancer Cell"},{"key":"8980_CR61","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1182\/blood-2016-10-741207","volume":"129","author":"SU Liyanage","year":"2017","unstructured":"Liyanage, S. U. et al. Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML. Blood 129, 2657\u20132666 (2017).","journal-title":"Blood"},{"key":"8980_CR62","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ccell.2019.06.003","volume":"36","author":"I Baccelli","year":"2019","unstructured":"Baccelli, I. et al. Mubritinib targets the electron transport chain complex I and reveals the landscape of OXPHOS dependency in acute myeloid leukemia. Cancer Cell 36, 84\u201399 e88 (2019).","journal-title":"Cancer Cell"},{"key":"8980_CR63","doi-asserted-by":"publisher","first-page":"100972","DOI":"10.1016\/j.currproblcancer.2023.100972","volume":"47","author":"M Hu","year":"2023","unstructured":"Hu, M., Chen, Y., Ma, T. & Jing, L. Repurposing metformin in hematologic tumor: state of art. Curr. Probl. Cancer 47, 100972 (2023).","journal-title":"Curr. Probl. Cancer"},{"key":"8980_CR64","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3390\/biom13020250","volume":"13","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., Zhou, F., Guan, J., Zhou, L. & Chen, B. Action mechanism of metformin and its application in hematological malignancy treatments: a review. Biomolecules 13, 250 (2023).","journal-title":"Biomolecules"},{"key":"8980_CR65","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/dom.12267","volume":"16","author":"ZJ Zhang","year":"2014","unstructured":"Zhang, Z. J. & Li, S. The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis. Diabetes Obes. Metab. 16, 707\u2013710 (2014).","journal-title":"Diabetes Obes. Metab."},{"key":"8980_CR66","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1158\/1078-0432.CCR-14-1088","volume":"21","author":"S Dalva-Aydemir","year":"2015","unstructured":"Dalva-Aydemir, S. et al. Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin. Clin. Cancer Res. 21, 1161\u20131171 (2015).","journal-title":"Clin. Cancer Res."},{"key":"8980_CR67","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.02242","volume":"3","author":"WW Wheaton","year":"2014","unstructured":"Wheaton, W. W. et al. Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis. eLife 3, e02242 (2014).","journal-title":"eLife"},{"key":"8980_CR68","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.leukres.2015.09.016","volume":"39","author":"F Wang","year":"2015","unstructured":"Wang, F. et al. Metformin synergistically sensitizes FLT3-ITD-positive acute myeloid leukemia to sorafenib by promoting mTOR-mediated apoptosis and autophagy. Leuk. Res. 39, 1421\u20131427 (2015).","journal-title":"Leuk. Res."},{"key":"8980_CR69","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ijcard.2008.04.010","volume":"134","author":"NL Huang","year":"2009","unstructured":"Huang, N. L. et al. Metformin inhibits TNF-\u03b1-induced I\u03baB kinase phosphorylation, I\u03baB-\u03b1 degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation. Int. J. Cardiol. 134, 169\u2013175 (2009).","journal-title":"Int. J. Cardiol."},{"key":"8980_CR70","doi-asserted-by":"publisher","first-page":"20348","DOI":"10.1074\/jbc.M115.662114","volume":"290","author":"B Kelly","year":"2015","unstructured":"Kelly, B., Tannahill, G. M., Murphy, M. P. & O\u2019Neill, L. A. Metformin inhibits the production of reactive oxygen species from NADH:ubiquinone oxidoreductase to limit induction of interleukin-1\u03b2 (IL-1\u03b2) and boosts interleukin-10 (IL-10) in lipopolysaccharide (LPS)-activated macrophages. J. Biol. Chem. 290, 20348\u201320359 (2015).","journal-title":"J. Biol. Chem."},{"key":"8980_CR71","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/onc.2017.367","volume":"37","author":"E Cuyas","year":"2018","unstructured":"Cuyas, E. et al. Metformin regulates global DNA methylation via mitochondrial one-carbon metabolism. Oncogene 37, 963\u2013970 (2018).","journal-title":"Oncogene"},{"key":"8980_CR72","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41588-022-01121-z","volume":"54","author":"SP Kar","year":"2022","unstructured":"Kar, S. P. et al. Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis. Nat. Genet. 54, 1155\u20131166 (2022).","journal-title":"Nat. Genet."},{"key":"8980_CR73","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil, E. et al. Genomic classification and prognosis in acute myeloid leukemia. N. Engl. J. Med. 374, 2209\u20132221 (2016).","journal-title":"N. Engl. J. Med."},{"key":"8980_CR74","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","volume":"122","author":"E Papaemmanuil","year":"2013","unstructured":"Papaemmanuil, E. et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 122, 3616\u20133627 (2013). quiz 3699.","journal-title":"Blood"},{"key":"8980_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32103-8","volume":"13","author":"Y Tazi","year":"2022","unstructured":"Tazi, Y. et al. Unified classification and risk-stratification in acute myeloid leukemia. Nat. Commun. 13, 4622 (2022).","journal-title":"Nat. Commun."},{"key":"8980_CR76","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1182\/bloodadvances.2021005927","volume":"6","author":"PM Quiros","year":"2022","unstructured":"Quiros, P. M., Gu, M., Barcena, C., Iyer, V. & Vassiliou, G. S. NPM1 gene mutations can be confidently identified in blood DNA months before de novo AML onset. Blood Adv. 6, 2409\u20132413 (2022).","journal-title":"Blood Adv."},{"key":"8980_CR77","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1126\/science.7660125","volume":"269","author":"R Kuhn","year":"1995","unstructured":"Kuhn, R., Schwenk, F., Aguet, M. & Rajewsky, K. Inducible gene targeting in mice. Science 269, 1427\u20131429 (1995).","journal-title":"Science"},{"key":"8980_CR78","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1182\/blood.V100.1.246","volume":"100","author":"HC Morse 3rd","year":"2002","unstructured":"Morse, H. C. 3rd et al. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 100, 246\u2013258 (2002).","journal-title":"Blood"},{"key":"8980_CR79","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1182\/blood.V100.1.238","volume":"100","author":"SC Kogan","year":"2002","unstructured":"Kogan, S. C. et al. Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood 100, 238\u2013245 (2002).","journal-title":"Blood"},{"key":"8980_CR80","unstructured":"Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. Preprint at https:\/\/arxiv.org\/abs\/1303.3997 (2013)."},{"key":"8980_CR81","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"8980_CR82","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"8980_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren, W. et al. The Ensembl variant effect predictor. Genome Biol. 17, 122 (2016).","journal-title":"Genome Biol."},{"key":"8980_CR84","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nbt.2800","volume":"32","author":"H Koike-Yusa","year":"2014","unstructured":"Koike-Yusa, H., Li, Y., Tan, E. P., Velasco-Herrera Mdel, C. & Yusa, K. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat. Biotechnol. 32, 267\u2013273 (2014).","journal-title":"Nat. Biotechnol."},{"key":"8980_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"8980_CR86","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/ng.3984","volume":"49","author":"RM Meyers","year":"2017","unstructured":"Meyers, R. M. et al. Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells. Nat. Genet. 49, 1779\u20131784 (2017).","journal-title":"Nat. Genet."},{"key":"8980_CR87","doi-asserted-by":"publisher","unstructured":"Dempster, J. M. et al. Extracting biological insights from the Project Achilles genome-scale CRISPR screens in cancer cell lines. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/720243 (2019).","DOI":"10.1101\/720243"},{"key":"8980_CR88","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinf. 14, 128 (2013).","journal-title":"BMC Bioinf."},{"key":"8980_CR89","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/nmeth.2689","volume":"10","author":"M Griffith","year":"2013","unstructured":"Griffith, M. et al. DGIdb: mining the druggable genome. Nat. Methods 10, 1209\u20131210 (2013).","journal-title":"Nat. Methods"},{"key":"8980_CR90","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41588-018-0114-z","volume":"50","author":"M Gozdecka","year":"2018","unstructured":"Gozdecka, M. et al. UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs. Nat. Genet. 50, 883\u2013894 (2018).","journal-title":"Nat. Genet."},{"key":"8980_CR91","first-page":"219","volume":"50","author":"EJ Freireich","year":"1966","unstructured":"Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H. & Skipper, H. E. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother. Rep. 50, 219\u2013244 (1966).","journal-title":"Cancer Chemother. Rep."},{"key":"8980_CR92","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch, J., Lees, M. & Sloane Stanley, G. H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497\u2013509 (1957).","journal-title":"J. Biol. Chem."},{"key":"8980_CR93","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2016.09.015","volume":"24","author":"SP Burr","year":"2016","unstructured":"Burr, S. P. et al. Mitochondrial protein lipoylation and the 2-oxoglutarate dehydrogenase complex controls HIF1alpha stability in aerobic conditions. Cell Metab. 24, 740\u2013752 (2016).","journal-title":"Cell Metab."},{"key":"8980_CR94","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.cell.2019.12.017","volume":"180","author":"MZ Cader","year":"2020","unstructured":"Cader, M. Z. et al. FAMIN Is a multifunctional purine enzyme enabling the purine nucleotide cycle. Cell 180, 278\u2013295 e223 (2020).","journal-title":"Cell"},{"key":"8980_CR95","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"The Cancer Genome Atlas Research Network","year":"2013","unstructured":"The Cancer Genome Atlas Research Network et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113\u20131120 (2013).","journal-title":"Nat. Genet."},{"key":"8980_CR96","unstructured":"Therneau, T. A package for survival analysis in R. R package version 3.5-8 https:\/\/CRAN.R-project.org\/package=survival (2024)."},{"key":"8980_CR97","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","volume":"562","author":"C Bycroft","year":"2018","unstructured":"Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203\u2013209 (2018).","journal-title":"Nature"},{"key":"8980_CR98","doi-asserted-by":"crossref","unstructured":"Wen, S. et al. Comparative analysis of the Mexico City Prospective Study and the UK Biobank identifies ancestry-specific effects on clonal hematopoiesis. Nat. Genet. 57, 572\u2013582 (2025).","DOI":"10.1038\/s41588-025-02085-6"},{"key":"8980_CR99","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add5430","volume":"8","author":"A Nag","year":"2022","unstructured":"Nag, A. et al. Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes. Sci. Adv. 8, eadd5430 (2022).","journal-title":"Sci. Adv."},{"key":"8980_CR100","doi-asserted-by":"crossref","unstructured":"Chen, F. et al. The association between type 2 diabetes and asthma incidence: a longitudinal analysis considering genetic susceptibility. BMC Public Health 25, 166 (2025).","DOI":"10.1186\/s12889-024-21266-2"},{"key":"8980_CR101","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41588-021-00870-7","volume":"53","author":"J Mbatchou","year":"2021","unstructured":"Mbatchou, J. et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat. Genet. 53, 1097\u20131103 (2021).","journal-title":"Nat. Genet."},{"key":"8980_CR102","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife 7, e34408 (2018).","journal-title":"eLife"},{"key":"8980_CR103","doi-asserted-by":"publisher","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani, G., Tilling, K. & Davey Smith, G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 13, e1007081 (2017).","journal-title":"PLoS Genet."},{"key":"8980_CR104","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1093\/ije\/dyab084","volume":"50","author":"C Minelli","year":"2021","unstructured":"Minelli, C. et al. The use of two-sample methods for Mendelian randomization analyses on single large datasets. Int. J. Epidemiol. 50, 1651\u20131659 (2021).","journal-title":"Int. J. Epidemiol."},{"key":"8980_CR105","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nbt.1754","volume":"29","author":"JT Robinson","year":"2011","unstructured":"Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24\u201326 (2011).","journal-title":"Nat. Biotechnol."},{"key":"8980_CR106","unstructured":"DepMap 19Q4 Public. Figshare https:\/\/figshare.com\/articles\/dataset\/ DepMap_19Q4_Public\/11384241\/3 (2020)."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-08980-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-08980-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-08980-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T03:03:31Z","timestamp":1749697411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-025-08980-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":106,"journal-issue":{"issue":"8067","published-print":{"date-parts":[[2025,6,12]]}},"alternative-id":["8980"],"URL":"https:\/\/doi.org\/10.1038\/s41586-025-08980-6","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]},"assertion":[{"value":"19 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.S.V. is a consultant for STRM.BIO and receives a research grant from AstraZeneca. S.W., J.M. and M.A.F. are current employees and\/or stockholders of AstraZeneca. K.T. has received consultancy fees, stock options and research funding from Storm Therapeutics Ltd., Cambridge, UK. K.T. is a cofounder of Btwo3 Therapeutics LLC, USA and TEP Therapeutics LLC, USA. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}